Finally, reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was used to validate the expression of GRP, NPPB, SERPINE1, GAMT, MMRN1, and SLC22A16 in GC and paracarcinoma tissue. Here, SLC22A16 is linked to gastric cancer.